INMB
INmune Bio·NASDAQ
--
--(--)
--
--(--)
4.31 / 10
Netural
The fund flow profile scores 7.69/10, demonstrating robust fund flow characteristics. Favorable Large movements are tempered by challenging overall, block, Small, Medium, and Extra-large dynamics, supporting positive flow assessment. Analyst sentiment reflects divided analyst consensus with neutral perspective. The rating profile includes Strong Buy(33.3%), Neutral(33.3%), Strong Sell(33.3%) from 3 analytical reports, supported by 0.92 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
33%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
33%
Date2025-07-01
InstitutionScotiabank
Times predicted2
Historical Win Rate0.0%
What is the market sentiment for INMB?
- INMB holds a Bearish analyst rating, with 33% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.31/10 (Netural).
